Rituximab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
non-site specific oxidation
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
sequencing antibody
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
lucatumumab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
recombinant antibody
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
Golimumab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
monoclonal sequencing
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
de novo sequence
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
varlilumab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
Siplizumab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
setoxaximab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
Narnatumab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
mice antibody
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
sequencing antibodies
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
octet system
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
glycosylation motif
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
phage display screening
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
de novo protein sequencing
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
Adalimumab
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967
sequencing antibody
45-1 Ramsey Road, Shirley, NY 11967, USA, Shirley, New York, 11967